News | Treatment Planning | September 15, 2016

RapidPlan Shown to Improve Treatment Planning Quality for Radiotherapy and Radiosurgery

Varian’s treatment planning software found to enhance knowledge-based planning for multiple cancer sites, including prostate, uterine cervix and vaginal cancers

Varian, RapidPlan treatment planning software, radiotherapy, radiosurgery, AAPM 2016 research

September 14, 2016 — RapidPlan knowledge-based treatment planning software can improve quality control in radiotherapy and radiosurgery treatment plans, according to research presented at the 2016 American Association of Physicists in Medicine (AAPM). Researchers found that using the RapidPlan tool from Varian Medical Systems helped them develop plans that improved targeting of tumors and spared more healthy tissue.

RapidPlan is a machine-learning tool that studies best practices from past successful treatment plans and creates knowledge-based treatment models that are applied to improve the treatment plans for future patients. These RapidPlan models help to quickly generate and validate new high-quality treatment plans based on shared expertise. 

Kathryn Masi and Maria Ditman from the University of Michigan, Ann Arbor, found that RapidPlan software creates consistent, efficient, quality plans while standardizing the treatment planning process. They used a prostate-specific RapidPlan model, based on 60 prostate intensity-modulated radiation therapy (IMRT) plans. Applying their knowledge-based planning (KBP) model to 10 patients from four community-based clinics, they found that RapidPlan could improve the quality control of smaller community-based clinics by helping them "identify the areas in their treatment plans that may be improved whether that be in normal tissue sparing or improved target coverage."1

Similar findings were reported by researchers conducting a multi-institutional phase II clinical trial sponsored by the National Clinical Trials Network (NCTN) for patients with uterine cervix or vaginal cancer. Using a KBP model, researchers reported that RapidPlan greatly improved plan quality assurance for IMRT pre-treatment plans.

The use of RapidPlan is expanding to other areas, including motion management for treating lung cancer during stereotactic body radiation therapy (SBRT). Ronald Lalonde, M. Saiful Huq and Dwight Heronfrom UPMC, Pittsburgh, Pennsylvania, found that RapidPlan "may be a useful tool in identifying patients where motion management may be necessary for SBRT treatment."3

For more information: www.varian.com

Related Content

Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
150-Year-Old Drug Might Improve Radiation Therapy for Cancer
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more
A model of the new, compact, single-room Varian ProBeam 360 system. The system is an example of the trend in proton therapy toward single-room, smaller systems and away from multi-room treatment centers. #ASTRO18 #ASTRO2018

A model of the new, compact, single-room Varian ProBeam 360 system. The system is an example of the trend in proton therapy toward single-room, smaller systems and away from multi-room treatment centers.

Feature | Proton Therapy | November 01, 2018 | Dave Fornell, Editor
A few of the big takeaways from the American Societ...